Source link : https://newshealth.biz/health-news/targeted-tablet-approved-for-esr1-breast-cancer/
MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer. Medscape News UK Source link : https://www.medscape.com/viewarticle/targeted-tablet-approved-esr1-breast-cancer-2026a10005xy?src=rss Author : Publish date : 2026-02-25 14:11:00 Copyright for syndicated content belongs to the linked Source.
The post Targeted Tablet Approved for ESR1 Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-25 14:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8